FI912124A7 - Menetelmä terapeuttisesti aktiivisten pyrido/2,3-f//1,4/tiatsepiini- ja pyrido/3,2-b//1,5/bentsotiatsepiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti aktiivisten pyrido/2,3-f//1,4/tiatsepiini- ja pyrido/3,2-b//1,5/bentsotiatsepiinijohdannaisten valmistamiseksi

Info

Publication number: FI912124A7
Authority: FI; Finland
Prior art keywords: pyrido; thiazepine; preparation; therapeutically active; benzothiazepine derivatives
Prior art date: 1990-05-03

Application number

FI912124A

Other languages

English (en)

Swedish (sv)

Other versions

FI912124A0 (fi

FI95912C (fi

FI95912B (fi

Inventor

David J Wustrow

John H Dodd

Charles F Schwender

Original Assignee

Ortho Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-05-03

Filing date

1991-05-02

Publication date

1991-11-04

1991-05-02 Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp

1991-05-02 Publication of FI912124A0 publication Critical patent/FI912124A0/fi

1991-11-04 Publication of FI912124A7 publication Critical patent/FI912124A7/fi

1995-12-29 Application granted granted Critical

1995-12-29 Publication of FI95912B publication Critical patent/FI95912B/fi

1996-04-10 Publication of FI95912C publication Critical patent/FI95912C/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Immunology (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Luminescent Compositions (AREA)
Plural Heterocyclic Compounds (AREA)

FI912124A 1990-05-03 1991-05-02 Menetelmä terapeuttisesti aktiivisten pyrido/2,3-f//1,4/tiatsepiini- ja pyrido/3,2-b//1,5/bentsotiatsepiinijohdannaisten valmistamiseksi FI95912C (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US07/518,351 US5075440A (en)	1990-05-03	1990-05-03	Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines
US51835190		1990-05-03

Publications (4)

Publication Number	Publication Date
FI912124A0 FI912124A0 (fi)	1991-05-02
FI912124A7 true FI912124A7 (fi)	1991-11-04
FI95912B FI95912B (fi)	1995-12-29
FI95912C FI95912C (fi)	1996-04-10

Family

ID=24063558

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI912124A FI95912C (fi)	1990-05-03	1991-05-02	Menetelmä terapeuttisesti aktiivisten pyrido/2,3-f//1,4/tiatsepiini- ja pyrido/3,2-b//1,5/bentsotiatsepiinijohdannaisten valmistamiseksi

Country Status (25)

Country	Link
US (1)	US5075440A (fi)
EP (1)	EP0462696B1 (fi)
JP (1)	JP3296499B2 (fi)
KR (1)	KR100195345B1 (fi)
CN (2)	CN1034077C (fi)
AT (1)	ATE126231T1 (fi)
AU (1)	AU651580B2 (fi)
CA (1)	CA2041594C (fi)
DE (1)	DE69111915T2 (fi)
DK (1)	DK0462696T3 (fi)
ES (1)	ES2079570T3 (fi)
FI (1)	FI95912C (fi)
GR (1)	GR3017305T3 (fi)
HK (1)	HK51496A (fi)
HU (1)	HU218909B (fi)
IE (1)	IE68524B1 (fi)
IL (6)	IL97999A (fi)
MY (1)	MY106552A (fi)
NO (1)	NO179411C (fi)
NZ (1)	NZ237988A (fi)
PT (1)	PT97547B (fi)
TN (1)	TNSN91030A1 (fi)
TW (1)	TW218878B (fi)
ZA (1)	ZA913319B (fi)
ZW (1)	ZW5291A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6593335B1 (en) *	1997-12-18	2003-07-15	Abbott Laboratories	Potassium channel openers
SK8732000A3 (en) *	1997-12-18	2000-11-07	Abbott Lab	Potassium channel openers
US6265417B1 (en)	1997-12-18	2001-07-24	Abbott Laboratories	Potassium channel openers
JPH11193289A (ja) *	1997-12-26	1999-07-21	Suntory Ltd	ピロールスルホンアミド誘導体
US6482854B1 (en) *	1999-03-25	2002-11-19	Massachusetts Eye And Ear Infirmary	Glaucoma treatment
US7015212B1 (en)	1999-05-12	2006-03-21	The United States Of America As Represented By The Department Of Health And Human Services	Thiazepine inhibitors of HIV-1 integrase
DE60005349T2 (de) *	1999-06-14	2004-12-30	Ortho-Mcneil Pharmaceutical, Inc.	Dithiepino[6,5-b]pyridine und diese verwendete zusamensetzungen und methode
ES2246248T3 (es) *	1999-07-12	2006-02-16	Ortho-Mcneil Pharmaceutical, Inc.	Oxatiepino (6,5-b)dihidropiridinas, y composiciones y metodos relacionados.
US6472530B1 (en)	1999-09-22	2002-10-29	Ortho-Mcneil Pharmaceutical, Inc.	Benzo-fused dithiepino[6,5-b]pyridines, and related compositions and methods
CN1301997C (zh) *	2000-01-12	2007-02-28	奥索-麦克尼尔药品公司	具有钙拮抗剂活性的苯并砜
WO2001055152A1 (en) *	2000-01-27	2001-08-02	Ortho-Mcneil Pharmaceutical, Inc..	BENZOXATHIEPINO[3,4-b]PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
AU4732001A (en)	2000-03-23	2001-10-03	Ortho Mcneil Pharm Inc	Thiepino (3,2-b) dihydropyridines and related compositions and methods
AU2001261161A1 (en)	2000-05-30	2001-12-11	Ortho-Mcneil Pharmaceutical, Inc.	Dihydropyridine compounds for inhibition of calcium-influx
KR101233139B1 (ko)	2011-04-21	2013-02-21	주식회사 한서켐	라세믹 1,4-티아제핀 화합물의 분할 방법
WO2016109596A1 (en) *	2014-12-30	2016-07-07	Myotherix, Inc.	Novel calcium modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1587128A (en) *	1977-04-07	1981-04-01	Hexachimie	Benzothiazepine derivatives
US4285955A (en) *	1978-10-31	1981-08-25	Bayer Aktiengesellschaft	1,4-Dihydropyridinecarboxylic acids
NZ201395A (en) *	1981-07-30	1987-02-20	Bayer Ag	Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
FR2511683A1 (fr) *	1981-08-20	1983-02-25	Hexachimie	Nouveaux derives de la pyrido (2,3-b) benzothiazepine(1,5) substituee en 5 par une carboxypiperazine, leur procede de preparation, leur application en therapeutique
EP0225175A3 (en) *	1985-11-28	1988-12-28	FISONS plc	Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof

1990
- 1990-05-03 US US07/518,351 patent/US5075440A/en not_active Expired - Lifetime
1991
- 1991-04-29 IL IL97999A patent/IL97999A/xx not_active IP Right Cessation
- 1991-04-29 NZ NZ237988A patent/NZ237988A/xx unknown
- 1991-04-29 IL IL12704791A patent/IL127047A/xx not_active IP Right Cessation
- 1991-04-29 IL IL12044697A patent/IL120446A0/xx unknown
- 1991-04-29 IL IL12044797A patent/IL120447A/xx not_active IP Right Cessation
- 1991-04-29 IL IL12044691A patent/IL120446A/xx not_active IP Right Cessation
- 1991-04-29 IL IL12704798A patent/IL127047A0/xx unknown
- 1991-05-01 CA CA002041594A patent/CA2041594C/en not_active Expired - Fee Related
- 1991-05-02 FI FI912124A patent/FI95912C/fi active
- 1991-05-02 NO NO911723A patent/NO179411C/no unknown
- 1991-05-02 EP EP91303970A patent/EP0462696B1/en not_active Expired - Lifetime
- 1991-05-02 AT AT91303970T patent/ATE126231T1/de not_active IP Right Cessation
- 1991-05-02 ES ES91303970T patent/ES2079570T3/es not_active Expired - Lifetime
- 1991-05-02 KR KR1019910007086A patent/KR100195345B1/ko not_active Expired - Fee Related
- 1991-05-02 ZA ZA913319A patent/ZA913319B/xx unknown
- 1991-05-02 PT PT97547A patent/PT97547B/pt not_active IP Right Cessation
- 1991-05-02 DK DK91303970.7T patent/DK0462696T3/da active
- 1991-05-02 ZW ZW52/91A patent/ZW5291A1/xx unknown
- 1991-05-02 MY MYPI91000748A patent/MY106552A/en unknown
- 1991-05-02 JP JP13047291A patent/JP3296499B2/ja not_active Expired - Fee Related
- 1991-05-02 HU HU476/91A patent/HU218909B/hu not_active IP Right Cessation
- 1991-05-02 DE DE69111915T patent/DE69111915T2/de not_active Expired - Fee Related
- 1991-05-02 IE IE148891A patent/IE68524B1/en not_active IP Right Cessation
- 1991-05-02 AU AU76354/91A patent/AU651580B2/en not_active Ceased
- 1991-05-03 CN CN91103594A patent/CN1034077C/zh not_active Expired - Fee Related
- 1991-05-03 TN TNTNSN91030A patent/TNSN91030A1/fr unknown
- 1991-07-20 TW TW080105637A patent/TW218878B/zh active
1995
- 1995-07-29 CN CN95109346A patent/CN1039416C/zh not_active Expired - Fee Related
- 1995-09-06 GR GR950402432T patent/GR3017305T3/el unknown
1996
- 1996-03-21 HK HK51496A patent/HK51496A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN1056880A (zh)	1991-12-11
IE68524B1 (en)	1996-06-26
PT97547B (pt)	1998-08-31
IL120447A (en)	1999-12-22
PT97547A (pt)	1992-01-31
KR100195345B1 (ko)	1999-06-15
TNSN91030A1 (fr)	1992-10-25
ZW5291A1 (en)	1993-01-06
NZ237988A (en)	1992-09-25
HU218909B (hu)	2000-12-28
NO179411B (no)	1996-06-24
FI912124A0 (fi)	1991-05-02
TW218878B (fi)	1994-01-11
FI95912C (fi)	1996-04-10
NO911723D0 (no)	1991-05-02
IL127047A0 (en)	1999-09-22
CA2041594C (en)	2002-07-23
DE69111915T2 (de)	1996-01-04
HU911476D0 (en)	1991-11-28
CN1034077C (zh)	1997-02-19
IL120447A0 (en)	1997-07-13
NO179411C (no)	1996-10-02
IE911488A1 (en)	1991-11-06
IL120446A (en)	2000-08-31
JP3296499B2 (ja)	2002-07-02
DE69111915D1 (de)	1995-09-14
IL97999A0 (en)	1992-06-21
GR3017305T3 (en)	1995-12-31
CN1118783A (zh)	1996-03-20
IL120446A0 (en)	1997-07-13
FI95912B (fi)	1995-12-29
EP0462696B1 (en)	1995-08-09
CN1039416C (zh)	1998-08-05
IL127047A (en)	2000-10-31
ZA913319B (en)	1993-01-27
HK51496A (en)	1996-03-29
ES2079570T3 (es)	1996-01-16
ATE126231T1 (de)	1995-08-15
JPH04225986A (ja)	1992-08-14
AU7635491A (en)	1991-11-07
AU651580B2 (en)	1994-07-28
IL97999A (en)	1997-06-10
HUT60745A (en)	1992-10-28
DK0462696T3 (da)	1995-09-18
MY106552A (en)	1995-06-30
KR910020019A (ko)	1991-12-19
NO911723L (no)	1991-11-04
EP0462696A1 (en)	1991-12-27
US5075440A (en)	1991-12-24
CA2041594A1 (en)	1991-11-04

Publication	Publication Date	Title
FI96861C (fi)	1996-09-10	Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
NO175478C (no)	1994-10-19	Analogifremgangsmåte for fremstilling av terapeutisk aktive diazepin-derivater
NO914667L (no)	1992-05-29	Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater
NO903088L (no)	1991-01-14	Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater.
FI881900A7 (fi)	1988-10-25	Analogiamenetelmä terapeuttisesti käyttökelpoisten substituoitujen imidatsolyylialkyylipiperatsiini- ja -diatsepiinijohdannaisten valmistamiseksi
FI883739A7 (fi)	1989-02-15	Menetelmä terapeuttisesti aktiivisten fenoksi-indaanimetyyliamiinijohdannaisten valmistamiseksi
FI891361A7 (fi)	1989-09-26	Menetelmä farmaseuttisesti vaikuttavien aryylihydratsonien valmistamiseksi
FI95570C (fi)	1996-02-26	Menetelmä lääkinnällisesti vaikuttavien pyridatsinoni-3(2H)-onijohdannaisten valmistamiseksi
FI900813A0 (fi)	1990-02-19	Menetelmä uusien terapeuttisesti käyttökelpoisten bentsatsepiini- ja bentsotiatsepiinijohdannaisten valmistamiseksi
FI912124A7 (fi)	1991-11-04	Menetelmä terapeuttisesti aktiivisten pyrido/2,3-f//1,4/tiatsepiini- ja pyrido/3,2-b//1,5/bentsotiatsepiinijohdannaisten valmistamiseksi
FI890072A0 (fi)	1989-01-06	Menetelmä farmaseuttisesti käyttökelpoisten isokinoliinijohdannaisten valmistamiseksi
FI930723L (fi)	1993-02-18	Menetelmä terapeuttisesti aktiivisten tiatsolidiinijohdannaisten valmistamiseksi
NO175528C (no)	1994-10-26	Analogifremgangsmåte for fremstilling av terapeutisk aktive fenylacetamid-derivater
FI891910A0 (fi)	1989-04-21	Menetelmä uusien terapeuttisesti käyttökelpoisten pyrido/1,2,3-de//1,4/bentsoksatsiinijohdannaisten valmistamiseksi
NO173334C (no)	1993-12-01	Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
FI894520A7 (fi)	1989-09-25	Menetelmä terapeuttisesti aktiivisten 8-aminosubstituoitu-7,8-dihydro-6,6-dimetyyli-6H-pyrano/2,3-f/bentso-2,1,3-oksadiatsolien valmistamiseksi
FI892684L (fi)	1989-12-02	Menetelmä terapeuttisesti aktiivisten 4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
NO174774C (no)	1994-07-06	Analogifremgangsmåte for fremstilling av terapeutisk aktive benzodiazepiner
NO173606C (no)	1994-01-05	Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno- triazolo-diazepin-derivater
FI895333A0 (fi)	1989-11-09	Menetelmä terapeuttisesti käyttökelpoisten pyrrolokinoliini-, -bentsotiatsiini-, -akridiini-, -fenoksatsiini- ja -fenotiatsiinijohdannaisten valmistamiseksi
FI871535A7 (fi)	1987-10-10	Menetelmä terapeuttisesti aktiivisten tiasykloalkeno/3,2-b/pyridiinien valmistamiseksi
FI922835L (fi)	1992-06-17	Menetelmä terapeuttisesti aktiivisten piperidiinijohdannaisten valmistamiseksi
FI925518L (fi)	1992-12-04	Menetelmä terapeuttisesti aktiivisten 1-piperidinyylialkanoyyliaryylisulfonamidijohdannaisten valmistamiseksi
FI931894L (fi)	1993-04-27	Menetelmä uusien terapeuttisesti käyttökelpoisten 2,3-dihydroksi-pyratsino/2,3-f/kinoksaliini- ja pyratsino/2,3-g//1,5/bentsodiatsepiinijohdannaisten valmistamiseksi
NO904470D0 (no)	1990-10-16	Fremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater.

Legal Events

Date	Code	Title	Description
1995-12-01	BB	Publication of examined application